Plasma MMP1 and MMP8 expression in breast cancer: Protective role of MMP8 against lymph node metastasis

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Decock, Julie ^a   Hendrickx, Wouter ^a,b   Vanleeuw, Ulla ^a   Van Belle, Vanya ^a   Van Huffel, Sabine ^a   Christiaens, Marie Rose ^b   Ye, Shu ^c   Paridaens, Robert ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; INTERSTITIAL COLLAGENASE; NEUTROPHIL COLLAGENASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE PREDISPOSITION; DISTANT METASTASIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NORMAL VALUE; PREMENOPAUSE; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; BLOOD; BREAST TUMOR; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 8; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 41749096366     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-77     Document Type: Article

References (29)

1. Ferlay J Autier P Boniol M Heanue M Colombet M Boyle P Estimates of the cancer incidence and mortality in Europe in 2006 Ann Oncol 2007, 18:581-592. 10.1093/annonc/mdl498 17287242
2. Weigelt B Wessels LF Bosma AJ Glas AM Nuyten DS He YD Dai H Peterse JL van't Veer LJ No common denominator for breast cancer lymph node metastasis Br J Cancer 2005, 93:924-932. 10.1038/sj.bjc.6602794 16189523
3. Egeblad M Werb Z New functions for the matrix metalloproteinases in cancer progression Nat Rev Cancer 2002, 2:161-174. 10.1038/nrc745 11990853
4. Deryugina EI Quigley JP Matrix metalloproteinases and tumor metastasis Cancer Metastasis Rev 2006, 25:9-34. 10.1007/s10555-006-7886-9 16680569
5. Coskun U Yamac D Gulbahar O Sancak B Karaman N Ozkan S Locally advanced breast carcinoma treated with neoadjuvant chemotherapy: Are the changes in serum levels of YKL-40, MMP-2 and MMP-9 correlated with tumor response? Neoplasma 2007, 54:348-352. 17845129
6. Farias E Ranuncolo S Cresta C Specterman S Armanasco E Varela M Lastiri J Pallotta MG Bal De Kier JE Puricelli L Plasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patients Int J Cancer 2000, 89:389-394. 10.1002/ 1097-0215(20000720)89:4<389::AID-IJC12>3.0.CO;2-J 10956415
7. La Rocca G Pucci-Minafra I Marrazzo A Taormina P Minafra S Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera Br J Cancer 2004, 90:1414-1421. 10.1038/sj.bjc.6601725 15054465
8. Leppa S Saarto T Vehmanen L Blomqvist C Elomaa I A high serum matrix metalloproteinase-2 level is associated with an adverse prognosis in node-positive breast carcinoma Clin Cancer Res 2004, 10:1057-1063. 10.1158/1078-0432.CCR-03-0047 14871985
9. Liu SC Yang SF Yeh KT Yeh CM Chiou HL Lee CY Chou MC Hsieh YS Relationships between the level of matrix metalloproteinase-2 and tumor size of breast cancer Clin Chim Acta 2006, 371:92-96. 10.1016/ j.cca.2006.02.026 16581051
10. Quaranta M Daniele A Coviello M Venneri MT Abbate I Caringella ME Di TS Divella R Trerotoli P Di GM Schittulli F Fransvea E Giannelli G MMP-2, MMP-9, VEGF and CA 15.3 in breast cancer Anticancer Res 2007, 27:3593-3600. 17972522
11. Ranuncolo SM Armanasco E Cresta C Bal De Kier JE Puricelli L Plasma MMP-9 (92 kDa-MMP) activity is useful in the follow-up and in the assessment of prognosis in breast cancer patients Int J Cancer 2003, 106:745-751. 10.1002/ijc.11288 12866035
12. Sheen-Chen SM Chen HS Eng HL Sheen CC Chen WJ Serum levels of matrix metalloproteinase 2 in patients with breast cancer Cancer Lett 2001, 173:79-82. 10.1016/S0304-3835(01)00657-7 11578812
13. Talvensaari-Mattila A Turpeenniemi-Hujanen T Preoperative serum MMP-9 immunoreactive protein is a prognostic indicator for relapse-free survival in breast carcinoma Cancer Lett 2005, 217:237-242. 10.1016/ j.canlet.2004.06.056 15617842
14. Zucker S Lysik RM Zarrabi MH Moll U M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer Cancer Res 1993, 53:140-146. 8416738
15. Zucker S Hymowitz M Conner C Zarrabi HM Hurewitz AN Matrisian L Boyd D Nicolson G Montana S Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications Ann N Y Acad Sci 1999, 878:212-227. 10.1111/ j.1749-6632.1999.tb07687.x 10415733
16. Ala-aho R Kahari VM Collagenases in cancer Biochimie 2005, 87:273-286. 10.1016/j.biochi.2004.12.009 15781314
17. Rodriguez FO Fernandez Gomez JM Palou RJ Escaf BS Vizoso F Villavicencio MH Significance of collagenase 3 (matrix metalloproteinase 13) in invasive bladder cancer: Correlation with pathological parameters Urol Int 2007, 78:140-144. 10.1159/000098072 17293654
18. Van Lint P Libert C Matrix metalloproteinase-8: Cleavage can be decisive Cytokine Growth Factor Rev 2006, 17:217-223. 10.1016/ j.cytogfr.2006.04.001 16820317
19. Mannello F Tonti GA Gelatinase concentrations and zymographic profiles in human breast cancer: Matrix metalloproteinases circulating in plasma are better markers for the subclassification and early prediction of cancer: The coagulation/fibrinolysis pathways alter the release, activation and recovery of different gelatinases in serum Int J Cancer 2007, 121:216-218. 10.1002/ijc.22652 17315186
20. Gonzalez-Angulo AM Hennessy BT Broglio K Meric-Bernstam F Cristofanilli M Giordano SH Buchholz TA Sahin A Singletary SE Buzdar AU Hortobagyi GN Trends for inflammatory breast cancer: Is survival improving? Oncologist 2007, 12:904-912. 10.1634/theoncologist.12-8-904 17766649
21. Fowlkes JL Enghild JJ Suzuki K Nagase H Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures J Biol Chem 1994, 269:25742-25746. 7523391
22. Agarwal D Goodison S Nicholson B Tarin D Urquidi V Expression of matrix metalloproteinase 8 (MMP-8) and tyrosinase-related protein-1 (TYRP-1) correlates with the absence of metastasis in an isogenic human breast cancer model Differentiation 2003, 71:114-125. 10.1046/ j.1432-0436.2003.710202.x 12641565
23. Balbin M Fueyo A Tester AM Pendas AM Pitiot AS Astudillo A Overall CM Shapiro SD Lopez-Otin C Loss of collagenase-2 confers increased skin tumor susceptibility to male mice Nat Genet 2003, 35:252-257. 10.1038/ ng1249 14517555
24. Montel V Kleeman J Agarwal D Spinella D Kawai K Tarin D Altered metastatic behavior of human breast cancer cells after experimental manipulation of matrix metalloproteinase 8 gene expression Cancer Res 2004, 64:1687-1694. 10.1158/0008-5472.CAN-03-2047 14996728
25. Decock J Long JR Laxton RC Shu XO Hodgkinson C Hendrickx W Pearce EG Gao YT Pereira AC Paridaens R Zheng W Ye S Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis Cancer Res 2007, 67:10214-10221. 10.1158/0008-5472.CAN-07-1683 17974962
26. Moilanen M Pirila E Grenman R Sorsa T Salo T Expression and regulation of collagenase-2 (MMP-8) in head and neck squamous cell carcinomas J Pathol 2002, 197:72-81. 10.1002/path.1078 12081207
27. Stadlmann S Pollheimer J Moser PL Raggi A Amberger A Margreiter R Offner FA Mikuz G Dirnhofer S Moch H Cytokine-regulated expression of collagenase-2 (MMP-8) is involved in the progression of ovarian cancer Eur J Cancer 2003, 39:2499-2505. 10.1016/j.ejca.2003.08.011 14602136
28. Stenman M Paju A Hanemaaijer R Tervahartiala T Leminen A Stenman UH Konttinen YT Sorsa T Collagenases (MMP-1, -8 and -13) and trypsinogen-2 in fluid from benign and malignant ovarian cysts Tumour Biol 2003, 24:9-12. 10.1159/000070655 12743421
29. Overall CM Kleifeld O Tumour microenvironment - opinion: Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy Nat Rev Cancer 2006, 6:227-239. 10.1038/nrc1821 16498445